Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD

(Corresponding Author) Wu, L; Ma, L; Nicholson, Louise; Black, PN

dc.contributor.author	(Corresponding Author) Wu, L	en
dc.contributor.author	Ma, L	en
dc.contributor.author	Nicholson, Louise	en
dc.contributor.author	Black, PN	en
dc.coverage.spatial	England	en
dc.date.accessioned	2011-11-17T17:17:47Z	en
dc.date.issued	2011-03	en
dc.identifier.citation	Respiratory Medicine 105(3):329-336 Mar 2011	en
dc.identifier.issn	0954-6111	en
dc.identifier.uri	http://hdl.handle.net/2292/9224	en
dc.description.abstract	Advanced Glycation End products (AGEs) are the products of nonenzymatic glycation and oxidation of proteins and lipids. Formation of AGEs is increased in response to hyperglycaemia, reactive oxygen species and ageing. AGEs are proinflammatory and can modify the extracellular matrix. RAGE (Receptor for Advanced Glycation End Products) mediates some of the effects of AGEs.	en
dc.language	eng	en
dc.publisher	Elsevier Ltd.	en
dc.relation.ispartofseries	Respiratory Medicine	en
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/0954-6111/	en
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm	en
dc.subject	Aging	en
dc.subject	Cells, Cultured	en
dc.subject	Female	en
dc.subject	Glycosylation End Products, Advanced	en
dc.subject	Humans	en
dc.subject	Hyperglycemia	en
dc.subject	Lung	en
dc.subject	Male	en
dc.subject	Middle Aged	en
dc.subject	Oxidative Stress	en
dc.subject	Pulmonary Disease, Chronic Obstructive	en
dc.subject	Reactive Oxygen Species	en
dc.subject	Receptors, Immunologic	en
dc.subject	Smoking	en
dc.title	Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD	en
dc.type	Journal Article	en
dc.identifier.doi	10.1016/j.rmed.2010.11.001	en
pubs.issue	3	en
pubs.begin-page	329	en
pubs.volume	105	en
dc.rights.holder	Copyright: Elsevier Ltd.	en
dc.identifier.pmid	21112201	en
pubs.end-page	336	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/RestrictedAccess	en
pubs.subtype	Article	en
pubs.elements-id	190933	en
dc.identifier.eissn	1532-3064	en
dc.identifier.pii	S0954-6111(10)00475-0	en
pubs.record-created-at-source-date	2011-11-17	en
pubs.dimensions-id	21112201	en